Patient Surveillance After Cancer Treatment

Patient Surveillance After Cancer Treatment

Patient Surveillance After Cancer Treatment covers the history of cancer patient surveillance after curative-intent treatment, the rationale, the methodologies used in the past and at present, the methodologies that will probably emerge in the future, the costs of surveillance, the definitions of va...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Johnson, Frank E. (Editor), Maehara, Yoshihiko (Editor), Browman, George P. (Editor), Margenthaler, Julie A. (Editor), Audisio, Riccardo A. (Editor), Thompson, John F. (Editor), Johnson, David Y. (Editor), Earle, Craig C. (Editor), Virgo, Katherine S. (Editor)
Format: Electronic eBook
Language:English
Published: Totowa, NJ : Humana Press : Imprint: Humana Press, 2013.
Series:Current Clinical Oncology
Subjects:
Medicine.
Cancer research.
Radiotherapy.
Oncology.
Surgical oncology.
Medicine & Public Health.
Surgical Oncology.
Cancer Research.
Online Access:Full Text via HEAL-Link
Table of Contents:
  • 1. Overview
  • 2. Introduction to Cancer Surveillance Strategies
  • 3. Using Decision Analysis to Model Cancer Surveillance
  • 4. Cancer Survivorship: Monitoring the Long-Term and Late Effects of Treatment
  • 5. Upper Aerodigestive Tract Carcinoma
  • 6. Upper Aerodigestive Tract Carcinoma Surveillance Counterpoint: Europe
  • 7. Upper Aerodigestive Tract Carcinoma Surveillance Counterpoint: Japan
  • 8. Upper Aerodigestive Tract Carcinoma Surveillance Counterpoint: Canada
  • 9. Thyroid (Papillary, Follicular, Medullary, Hürthle Cell) Carcinoma
  • 10. Thyroid (Papillary, Follicular, Medullary, Hürthle Cell) Carcinoma Surveillance Counterpoint: Australia
  • 11. Thyroid (Papillary, Follicular, Medullary, Hürthle Cell) Carcinoma Surveillance Counterpoint: Japan
  • 12. Lung Carcinoma
  • 13. Lung Carcinoma Surveillance Counterpoint: Australia
  • 14. Lung Carcinoma Surveillance Counterpoint: Japan
  • 15. Lung Carcinoma Surveillance Counterpoint: Canada
  • 16. Esophagus Carcinoma
  • 17. Esophagus Carcinoma Surveillance Counterpoint: Australia
  • 18. Esophagus Carcinoma Surveillance Counterpoint: Japan
  • 19. Stomach
  • 20. Stomach Carcinoma Surveillance Counterpoint: USA
  • 21. Stomach Carcinoma Surveillance Counterpoint: Japan
  • 22. Pancreatic Adenocarcinoma
  • 23. Pancreatic Adenocarcinoma Surveillance Counterpoint: USA
  • 24. Pancreatic Adenocarcinoma Surveillance Counterpoint: Europe
  • 25. Pancreatic Adenocarcinoma Surveillance Counterpoint: Japan
  • 26. Pancreatic Adenocarcinoma Surveillance Counterpoint: Canada
  • 27. Liver and Biliary Tract Carcinoma
  • 28. Liver and Biliary Tract Carcinoma Surveillance Counterpoint: Europe
  • 29. Liver and Biliary Tract Carcinoma Surveillance Counterpoint: Australia
  • 30. Liver and Biliary Tract Carcinoma Surveillance Counterpoint: Japan
  • 31. Liver and Biliary Tract Carcinoma Surveillance Counterpoint: Canada
  • 32. Colon and Rectum Carcinoma
  • 33. Colon and Rectum Carcinoma Surveillance Counterpoint: USA
  • 34. Colon and Rectum Carcinoma Surveillance Counterpoint: Australia
  • 35. Colon and Rectum Carcinoma Surveillance Counterpoint: Japan
  • 36. Colon and Rectum Carcinoma Surveillance Counterpoint: Canada
  • 37. Anal Carcinoma
  • 38. Anal Carcinoma Surveillance Counterpoint: USA
  • 39. Anal Carcinoma Surveillance Counterpoint: Australia
  • 40. Anal Carcinoma Surveillance Counterpoint: Japan
  • 41. Anal Carcinoma Surveillance Counterpoint: Canada
  • 42. Soft Tissue Sarcoma
  • 43. Soft Tissue Sarcoma Surveillance Counterpoint: USA
  • 44. Soft-Tissue Sarcoma Surveillance Counterpoint: Japan
  • 45. Soft Tissue Sarcoma Surveillance Counterpoint: Canada
  • 46. Osteogenic Sarcoma and Dedifferentiated Chondrosarcoma
  • 47. Osteogenic Sarcoma and Dedifferentiated Chondrosarcoma Surveillance Counterpoint: Japan
  • 48. Osteogenic Sarcoma and Dedifferentiated Chondrosarcoma Surveillance Counterpoint: Canada
  • 49. Cutaneous Melanoma
  • 50. Cutaneous Melanoma Surveillance Counterpoint: USA
  • 51. Cutaneous Melanoma Surveillance Counterpoint: Australia
  • 52. Cutaneous Melanoma Surveillance Counterpoint: Japan
  • 53. Breast Carcinoma
  • 54. Breast Carcinoma Surveillance Counterpoint: USA
  • 55. Breast Carcinoma Surveillance Counterpoint: Europe
  • 56. Breast Carcinoma Surveillance Counterpoint: Australia
  • 57. Breast Carcinoma Surveillance Counterpoint: Japan
  • 58. Endometrial Carcinoma
  • 59. Endometrial Cancer Surveillance Counterpoint: USA
  • 60. Endometrial Cancer Surveillance Counterpoint: USA
  • 61. Carcinoma of the Endometrium Surveillance Counterpoint: Japan
  • 62. Endometrial Carcinoma Surveillance Counterpoint: Canada
  • 63. Cervical Carcinoma
  • 64. Cervical Carcinoma Surveillance Counterpoint: USA
  • 65. Cervical Carcinoma Surveillance Counterpoint: Japan
  • 66. Cervical Carcinoma Surveillance Counterpoint: Canada
  • 67. Vaginal and Vulvar Carcinoma
  • 68. Vaginal and Vulvar Carcinoma Surveillance Counterpoint: Japan
  • 69. Ovarian Carcinoma
  • 70. Ovarian Carcinoma Surveillance Counterpoint: USA
  • 71. Ovarian Cancer Surveillance Counterpoint: Europe
  • 72. Ovarian Cancer Surveillance Counterpoint: Japan
  • 73. Renal Carcinoma
  • 74. Renal Carcinoma Surveillance Counterpoint: Europe
  • 75. Renal Carcinoma Surveillance Counterpoint: Japan
  • 76. Renal Carcinoma Surveillance Counterpoint: Canada
  • 77. Urinary Bladder Carcinoma
  • 78. Urinary Bladder Carcinoma Surveillance Counterpoint: Japan
  • 79. Urinary Bladder Carcinoma Surveillance Counterpoint: Canada
  • 80. Prostate Carcinoma
  • 81. Prostate Carcinoma Surveillance Counterpoint: USA
  • 82. Prostate Carcinoma Surveillance Counterpoint: USA
  • 83. Prostate Carcinoma Surveillance Counterpoint: Europe
  • 84. Prostate Carcinoma Surveillance Counterpoint: Japan
  • 85. Prostate Carcinoma Surveillance Counterpoint: Canada
  • 86. Testicle Carcinoma
  • 87. Testicle Carcinoma Surveillance Counterpoint: USA
  • 88. Testicle Carcinoma Surveillance Counterpoint: Australia
  • 89. Testicle Carcinoma Surveillance Counterpoint: Japan
  • 90. Lymphoma
  • 91. Lymphoma Surveillance Counterpoint: USA
  • 92. Lymphoma Surveillance Counterpoint: Japan
  • 93. Lymphoma (Following Autologous Stem Cell Transplant)
  • 94. Lymphoma (Following Autologous Stem Cell Transplant) Surveillance Counterpoint: Japan
  • 95. Leukemia
  • 96. Leukemia Surveillance Counterpoint: USA
  • 97. Leukemia Surveillance Counterpoint: Japan
  • 98. Multiple Myeloma
  • 99. Multiple Myeloma Surveillance Counterpoint: USA
  • 100. Multiple Myeloma Surveillance Counterpoint: Australia
  • 101. Multiple Myeloma Surveillance Counterpoint: Japan
  • 102. Multiple Myeloma Surveillance Counterpoint: Canada
  • 103. Glioma of the Central Nervous System
  • 104. Glioma of the Central Nervous System Surveillance Counterpoint: Europe
  • 105. Glioma of the Central Nervous System Surveillance Counterpoint: Australia
  • 106. Glioma of the Central Nervous System Surveillance Counterpoint: Japan.                            .

Similar Items